Clinical Trial Update: Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial investigating riluzole in combination with sorafenib tosylate in patients with advanced solid tumors or melanoma; the study status is ACTIVE_NOT_R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Solid Tumors

Drugs mentioned

• Riluzole (riluzole)
• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Recurrent Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING